Candel Therapeutics Inc (CADL)

6.08 -0.67 (-9.93%) USD  |  NASDAQ  |  Dec 16, 15:21
More

Candel Therapeutics Enterprise Value: 217.57M for Dec. 13, 2024

Enterprise Value Chart

View Enterprise Value for CADL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Pfizer Inc 201.90B
AnaptysBio Inc 44.27M
Bristol-Myers Squibb Co 154.85B
Inovio Pharmaceuticals Inc -24.25M
NovaBay Pharmaceuticals Inc 2.090M

Enterprise Value Related Metrics

Net Income (Quarterly) -10.65M
Total Expenses (Quarterly) 8.757M
EPS Diluted (Quarterly) -0.33
Earnings Yield -28.45%
Normalized Earnings Yield -20.05